Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;53(10):704-717.
doi: 10.1055/s-0043-104600. Epub 2018 Nov 13.

[Pain Therapy Aspects in Tumour Surgery]

[Article in German]
Review

[Pain Therapy Aspects in Tumour Surgery]

[Article in German]
Stefan Wirz et al. Anasthesiol Intensivmed Notfallmed Schmerzther. 2018 Oct.

Abstract

Due to preexisting pain or surgically induced sensitization patients undergoing oncological surgery are predisposed for a postoperative high pain intensity with the risk of developing persistent pain. In oncological surgery, pain therapy should be adapted to the underlying pain mechanism. Different treatment principles should be applied in a graded concept of acute pain therapy. The rationale implies the "conventional" use of the WHO step scheme, the administration of opioids as PCA as well as regional analgesia and agents with anti-hypersensitizing properties. Anti-hypersensitizing and anti-neuropathic treatment principles may include the use of antidepressants, anticonvulsants, intravenous lidocaine and s-ketamine. Before using such treatment, pain mechanisms should be verified by an adequate pain diagnostic. The impact of perioperative regional analgesia on the oncological outcome is subject to controversy. Opioids reveal both: tumor promoting and tumor inhibiting properties.

Trotz einer Vielzahl von Therapieoptionen wird die Akutschmerztherapie nach onkologischen Operationen häufig als unzureichend beschrieben. Neben einer unzureichenden Akutschmerztherapie können weitere Faktoren eine Hypersensitivierung und Chronifizierung sowie den Verlauf der Tumorerkrankung beeinflussen. Dieser Beitrag erklärt pathophysiologische Hintergründe und erläutert geeignete Therapiemodalitäten.

PubMed Disclaimer

Conflict of interest statement

Dr. med. Stefan Wirz erhielt Honorare für Vortragstätigkeiten von Mundipharma, Grünenthal, AstraZeneca, KyowaKirin. Dr. med. Michael Schenk hat Honorare von den Firmen Grünenthal, Hormosan Indivior und Pfizer erhalten. Frau Dr. med. Kristin Kieselbach hat Honorare von Grünenthal erhalten. Darüber hinaus bestehen keine Interessenskonflikte.

LinkOut - more resources